People In Brief
This article was originally published in The Gray Sheet
Executive SummaryEdwards Lifesciences restructuring: Cardiovascular technology firm announces planned mid-year departures of corporate VPs Anita B. Bessler, Stuart L. Foster and Alex Martin, along with "strengthened alignment" into a business-unit organizational structure. Corporate VPs Donald E. Bobo, Paul C. Redmond, Carlyn D. Solomon and Larry L. Wood will take on additional U.S. sales, marketing and operational duties in their units, reporting to CEO Michael A. Mussallem. Bessler and Foster will continue in advisory roles with the company
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.